DME Capital Management »

Gain Therapeutics shares owned by DME Capital Management

Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by DME Capital Management from 13F filings

Historical chart of DME Capital Management investment in Gain Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Gain Therapeutics held by DME Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gain Therapeutics by DME Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1M 566k 3.77

More positions owned by DME Capital Management

Green Brick Partners (GRBK)
Brighthouse Finl (BHF)
Kyndryl Hldgs Common Stock (KD)
Consol Energy (CEIX)
Alight Com Cl A (ALIT)
Tenet Healthcare Corp Com New (THC)
ODP Corp. (ODP)
Penn National Gaming (PENN)
Livanova SHS (LIVN)
Teck Resources CL B (TECK)
Viatris (VTRS)
Graphic Packaging Holding Company (GPK)
Spdr Gold Tr Gold Shs (GLD)
Hp (HPQ)
Dht Holdings Shs New (DHT)

View all positions for DME Capital Management

Top funds holding Gain Therapeutics

Greenlight Capital
DME Capital Management
Raymond James & Associates
Royal Bank of Canada
Geode Capital Management
Vanguard Group
CM Management
BlackRock
Susquehanna International
Northern Trust
Millennium Management
Springbok Capital Management
Bridgeway Capital Management
Simplex Trading
Citadel Advisors

View all funds holding Gain Therapeutics